Related StoriesLow-fat diet programs do not lead to greater weight reduction in long term, shows meta-analysis researchUnderstanding how schizophrenia impacts workings of the brainProtein sensor for proprioception foundThe Bottom Line Dr. Funga’s work could be believed provoking and newsworthy, but she acknowledges that nothing in her research eliminates from recent clinical analysis and findings about medical benefits connected with low-carb diets. She acknowledges many of the weaknesses and limitations connected with long-term observational research, and the difficulties conducting them. In the last ten years, peer-reviewed journals have published more than 60 studies investigating low-carb diets, many of them predicated on Atkins protocols. All demonstrate positive results when it comes to weight loss, as well as improvements in lipid profiles, reduced irritation and better blood sugars control.Lexchin cites earlier analysis reviewing solid cancer medicines within a decade of EMA acceptance to point out these medicines improved survival by simply over a month. Similarly 71 medications authorized by the FDA from 2002 to 2014 for solid tumours have led to median benefits in progression-free and overall survival of only 2.5 and 2.1 months, respectively, he says adding, Also, only 42 percent met the American Society of Clinical Oncology Tumor Research Committee's requirements for meaningful outcomes for individuals. The authors discover that pharma companies are having an easy trip with the European and US regulators, who are permitting them to test tumor drugs using surrogate methods instead of survival and various other patient-centred measures..

Other articles from category "healthcare":

Random articles